Yoshio Miki
Tsukuba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications
Neoantigen dendritic cell vaccination combined with conventional chemotherapy for a patient with advanced transverse colon cancer.
Journal: Journal of surgical case reports
Published: October 20, 2025
Nuclear PD-L1 triggers tumour-associated inflammation upon DNA damage.
Journal: EMBO reports
Published: June 25, 2024
Functional evaluation of BRCA1/2 variants of unknown significance with homologous recombination assay and integrative in silico prediction model.
Journal: Journal of human genetics
Published: December 25, 2022
Discovery of novel DNA-damaging agents through phenotypic screening for DNA double-strand break.
Journal: Cancer science
Published: September 12, 2022
The BRCA2 missense mutation K2497R suppressed self-degradation and increased ATP production and cell proliferation.
Journal: Biochemical and biophysical research communications
Published: December 15, 2021
Regulation of Intrinsic Functions of PD-L1 by Post-Translational Modification in Tumors.
Journal: Frontiers in oncology
Published: November 30, 2021
BRCA2 represses the transcriptional activity of pS2 by E2-ERα.
Journal: Biochemical and biophysical research communications
Published: October 14, 2021
Integrative cancer genomics in the era of precision cancer medicine.
Journal: Journal of human genetics
Published: July 30, 2021
CDK1 inhibitor controls G2/M phase transition and reverses DNA damage sensitivity.
Journal: Biochemical and biophysical research communications
Published: February 01, 2021
Last Updated: 09/26/2026